Active ingredientLetermovirCat. No. P-L037-001CAS 917389-32-3Family · Pharmaceutical analytical standards
Letermovir
An antiviral against cytomegalovirus (CMV), approved in the United States in 2017 to prevent infection after haematopoietic stem cell transplantation and, since 2023, also in high-risk kidney transplants. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It has an unusual target: the terminase complex, which cuts the long chain of DNA made by the virus into single genomes to be packed into new viral particles.
Go to the active ingredient →Active ingredientLetermovirCat. No. P-L037-001CAS 917389-32-3
Isotopically labelledLetermovir-d3Cat. No. P-L037-002
Isotopically labelledLetermovir-d6Cat. No. P-L037-003
Isotopically labelledLetermovir-d8Cat. No. P-L037-004CAS 1961287-35-3
NitrosamineN-Nitroso Letermovir Impurity 1Cat. No. P-L037-005
NitrosamineN-Nitroso Letermovir Impurity 2Cat. No. P-L037-006
ImpurityLetermovir Impurity 1Cat. No. P-L037-008CAS 917389-23-2
Impurity2-Fluoro-6-nitrobenzaldehydeCat. No. P-L037-009CAS 1644-82-2
Impurity5-Fluoro Letermovir (mix of enantiomers)Cat. No. P-L037-010
Impurityent-LetermovirCat. No. P-L037-011CAS 917389-37-8
ImpurityLetermovir Ethyl EsterCat. No. P-L037-012CAS 2758792-79-7
ImpurityLetermovir Impurity 2Cat. No. P-L037-013
ImpurityLetermovir Impurity 3Cat. No. P-L037-014
ImpurityLetermovir Impurity 4Cat. No. P-L037-015
ImpurityLetermovir Impurity 5Cat. No. P-L037-016
ImpurityLetermovir Impurity 6Cat. No. P-L037-017CAS 917389-26-5
ImpurityLetermovir Impurity 7Cat. No. P-L037-018
ImpurityLetermovir Impurity 8Cat. No. P-L037-019
ImpurityLetermovir Impurity 9Cat. No. P-L037-020
ImpurityLetermovir Impurity 10Cat. No. P-L037-021
ImpurityLetermovir Impurity 11Cat. No. P-L037-022
ImpurityLetermovir Impurity 12Cat. No. P-L037-023CAS 2991299-71-7
ImpurityLetermovir Impurity 13Cat. No. P-L037-024CAS 2864441-31-4
ImpurityLetermovir Impurity 14Cat. No. P-L037-025
ImpurityLetermovir Impurity 15Cat. No. P-L037-026CAS 2758792-73-1
ImpurityLetermovir Impurity 16Cat. No. P-L037-027CAS 1917354-49-4
ImpurityLetermovir Impurity 17Cat. No. P-L037-028
ImpurityLetermovir Impurity 18Cat. No. P-L037-029
ImpurityLetermovir Impurity 19Cat. No. P-L037-030
ImpurityLetermovir Impurity 20Cat. No. P-L037-031CAS 2994645-03-1
ImpurityLetermovir Impurity 21Cat. No. P-L037-032
ImpurityLetermovir Impurity 22Cat. No. P-L037-033CAS 2991059-69-7
ImpurityLetermovir Impurity 23Cat. No. P-L037-034CAS 2991059-70-0
ImpurityLetermovir Impurity 24Cat. No. P-L037-035CAS 1450883-22-3
ImpurityLetermovir Impurity 25Cat. No. P-L037-036
ImpurityLetermovir Impurity 26Cat. No. P-L037-037
ImpurityLetermovir Impurity 27Cat. No. P-L037-038CAS 917389-34-5
ImpurityLetermovir Impurity 28Cat. No. P-L037-039CAS 917389-29-8
ImpurityLetermovir Impurity 29Cat. No. P-L037-040
ImpurityLetermovir N1-OxideCat. No. P-L037-041CAS 2991059-71-1
ImpurityN-(3-methoxyphenyl)piperazineCat. No. P-L037-043CAS 16015-71-7
ImpurityLetermovir Impurity 30Cat. No. P-L037-044CAS 884340-24-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.